Abstract
Hypertension (blood pressure (BP) > 140/90 mmHg) is a common comorbidity of type 2 DM (DM) and a major risk factor for macro- and microvascular complications. To review the effectiveness of different antihypertensive drugs in reducing BP, and diabetic complications in patients with DM, we analysed clinical trials, reviews and reports, published in Cochrane Library and PubMed from 1991 to 2004. Evidences suggest that optimal control of hypertension complications is obtained in diabetic patients when BP values are < 130/80 mmHg. Different drug classes result useful to obtain this target BP, but their effects on different metabolic and non-metabolic aspects have to be taken in account and a flexible approach according to individual response to different regimens is essential.
Keywords: Hypertension, DM, ACE-inhibitor, Diuretic, Calcium-channel blocker, Angiotensin-receptor blocker
Current Clinical Pharmacology
Title: Recommendations for the Treatment of Hypertension in Patients with DM: Critical Evaluation Based on Clinical Trials
Volume: 1 Issue: 1
Author(s): Giuseppe Derosa, Sibilla Salvadeo and Arrigo F.G. Cicero
Affiliation:
Keywords: Hypertension, DM, ACE-inhibitor, Diuretic, Calcium-channel blocker, Angiotensin-receptor blocker
Abstract: Hypertension (blood pressure (BP) > 140/90 mmHg) is a common comorbidity of type 2 DM (DM) and a major risk factor for macro- and microvascular complications. To review the effectiveness of different antihypertensive drugs in reducing BP, and diabetic complications in patients with DM, we analysed clinical trials, reviews and reports, published in Cochrane Library and PubMed from 1991 to 2004. Evidences suggest that optimal control of hypertension complications is obtained in diabetic patients when BP values are < 130/80 mmHg. Different drug classes result useful to obtain this target BP, but their effects on different metabolic and non-metabolic aspects have to be taken in account and a flexible approach according to individual response to different regimens is essential.
Export Options
About this article
Cite this article as:
Derosa Giuseppe, Salvadeo Sibilla and Cicero F.G. Arrigo, Recommendations for the Treatment of Hypertension in Patients with DM: Critical Evaluation Based on Clinical Trials, Current Clinical Pharmacology 2006; 1 (1) . https://dx.doi.org/10.2174/157488406775268237
DOI https://dx.doi.org/10.2174/157488406775268237 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
Related Articles
-
Ursolic Acid Attenuates HMGB1-induced LOX-1 Expression in Vascular Endothelial Cells in vitro and Inhibits Atherogenesis in Hypercholesterolemic Mice in vivo
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Diabetic Vasculopathy and the Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 (LOX-1)
Current Diabetes Reviews Thromboxane Synthase Inhibitors and Thromboxane A2 Receptor Antagonists: A Quantitative Structure Activity Relationships (QSARs) Analysis
Current Medicinal Chemistry Efficacy and Cardiovascular Safety of Alpha Glucosidase Inhibitors
Current Drug Safety Pharmacogenomics: Integration into Drug Discovery and Development
Current Topics in Medicinal Chemistry Transdermal Drug Delivery of Labetolol Hydrochloride: System Development, In Vitro; Ex Vivo and In Vivo Characterization
Current Drug Delivery Loading of Propranolol Hydrochloride on MCF and Sustained Release
Micro and Nanosystems Endothelial Dysfunction in Renal Failure: Current Update
Current Medicinal Chemistry Tacrolimus Treatment in Myasthenia Gravis
Current Drug Therapy Nanosystems for Skin Delivery: From Drugs to Cosmetics
Current Drug Metabolism Renal and Cardiac Effects of Renal Sympathetic Denervation and Carotid Baroreceptor Stimulation
Current Vascular Pharmacology Pathophysiological Basis for Anticoagulant and Antithrombotic Therapy in Pulmonary Hypertension
Cardiovascular & Hematological Agents in Medicinal Chemistry Diabetic Retinopathy in Pregnancy
Current Diabetes Reviews Editorial [Hot Topic: Food-Derived Bioactive Proteins and Peptides as Potential Components of Nutraceuticals (Executive Editor: H. Meisel)]
Current Pharmaceutical Design Cumulative HIV Viremia Copy-Years and Hypertension in People Living with HIV
Current HIV Research The Wnt/β-catenin Signalling Pathway Inhibitor Sclerostin is a Biomarker for Early Atherosclerosis in Obesity
Current Neurovascular Research Altered Prolylcarboxypeptidase Expression and Function in Response to Different Risk Factors of Diabetes
Cardiovascular & Hematological Agents in Medicinal Chemistry Clinical Pharmacology of Novel Anti-Alzheimer Disease Modifying Medications
Current Topics in Medicinal Chemistry Patients with Rheumatic Diseases Overlooked during COVID-19 Pandemic: How are They Doing and Behaving?
Current Rheumatology Reviews Obesity and Pregnancy
Current Women`s Health Reviews